Roy H. Decker, Ph.D.
Affiliations: | 2001 | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Oncology, Molecular BiologyGoogle:
"Roy Decker"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Steven Grant | grad student | 2001 | VCU | |
| (Role of oncogenes in resistance of leukemic cells to apoptosis induced by conventional and novel chemotherapeutic agents.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Saeed NA, Jin L, Amini A, et al. (2022) Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer. American Journal of Clinical Oncology. 46: 66-72 |
| Saeed NA, Jin L, Sasse AW, et al. (2022) Hypofractionated standard radiotherapy for locally advanced limited-stage small cell lung cancer. Journal of Thoracic Disease. 14: 306-320 |
| Raju SC, Peters GW, Decker RH, et al. (2021) Clinical Outcomes and Safety Profile in the Treatment of Synchronous Nonmetastatic Lung Tumors With Stereotactic Body Radiation Therapy. Practical Radiation Oncology. 12: e110-e116 |
| Jairam V, Pasha S, Soulos PR, et al. (2021) Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques. Lung Cancer (Amsterdam, Netherlands). 161: 171-179 |
| Saffarzadeh AG, Canavan M, Resio BJ, et al. (2021) Optimal Radiation Dose for Stage III Lung Cancer-Should "Definitive" Radiation Doses Be Used in the Preoperative Setting? Jto Clinical and Research Reports. 2: 100201 |
| Argiris A, Miao J, Cristea MC, et al. (2021) A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811). Clinical Lung Cancer |
| Daly ME, Ismaila N, Decker RH, et al. (2021) Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2003364 |
| Jairam V, Park HS, Decker RH. (2020) Local Ablative Therapies for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer. Cancer Journal (Sudbury, Mass.). 26: 129-136 |
| Jabbour SK, Berman AT, Decker RH, et al. (2020) Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial. Jama Oncology |
| Saeed NA, Kelly JR, Deshpande HA, et al. (2020) Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer. Head & Neck |